Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02495337
What this trial is testing

Tissue Collection Protocol for Gastroesophageal Cancers

Who this might be right for
Esophageal Cancer
University Health Network, Toronto 100
Testing effectiveness (Phase 2)WithdrawnNCT05312372
What this trial is testing

S095033 in Combination With Paclitaxel as 2nd- or 3rd-line Treatment in Participants With Advanced or Metastatic ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Institut de Recherches Internationales Servier
Testing effectiveness (Phase 2)UnknownNCT06010212
What this trial is testing

Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University 36
Testing effectiveness (Phase 2)Study completedNCT03426657
What this trial is testing

Radiotherapy With Double Checkpoint Blockade of Locally Advanced HNSCC

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
University of Erlangen-Nürnberg Medical School 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07744126
What this trial is testing

Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
AbbVie 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT06414577
What this trial is testing

Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy

Who this might be right for
Nasopharyngeal Cancer
XIANG YANQUN 38
Testing effectiveness (Phase 2)Ended earlyNCT04974944
What this trial is testing

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Who this might be right for
Stage IVB Cervical CancerRecurrent Cervical CancerPersistent Cervical Cancer
Sun Yat-Sen University Cancer Center 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT07142421
What this trial is testing

Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
First Affiliated Hospital of Zhejiang University 35
Testing effectiveness (Phase 2)UnknownNCT05749042
What this trial is testing

Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Xin-Hua Xu 70
Large-scale testing (Phase 3)Study completedNCT02741570
What this trial is testing

Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Bristol-Myers Squibb 947
Testing effectiveness (Phase 2)Study completedNCT01864772
What this trial is testing

Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC

Who this might be right for
Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Groupe Oncologie Radiotherapie Tete et Cou 85
Early research (Phase 1)Study completedNCT00909402
What this trial is testing

BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
Bristol-Myers Squibb 39
Early research (Phase 1)UnknownNCT04510818
What this trial is testing

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)

Who this might be right for
Head and Neck CancerEsophageal Squamous Cancer
Ruijin Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06155396
What this trial is testing

RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
RemeGen Co., Ltd. 116
Large-scale testing (Phase 3)Study completedNCT00261703
What this trial is testing

Docetaxel in Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Sanofi 439
Large-scale testing (Phase 3)Active Not RecruitingNCT06525220
What this trial is testing

Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merus B.V. 699
Testing effectiveness (Phase 2)Active Not RecruitingNCT04858269
What this trial is testing

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

Who this might be right for
Head Neck CancerMetastatic Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma+3 more
Wake Forest University Health Sciences 31
Large-scale testing (Phase 3)Active Not RecruitingNCT06304974
What this trial is testing

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 497
Testing effectiveness (Phase 2)Looking for participantsNCT05511623
What this trial is testing

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

Who this might be right for
Cervical Cancer
First Affiliated Hospital of Guangxi Medical University 112
Testing effectiveness (Phase 2)UnknownNCT03546855
What this trial is testing

Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.

Who this might be right for
Cervical Cancer
Anhui Provincial Hospital 69
Next Page